Innate immune receptor C5aR1 regulates cancer cell fate and can be targeted to improve radiotherapy in tumours with immunosuppressive microenvironments
Beach, C.; MacLean, D.; Majorova, D.; Melemenidis, S.; Nambiar, D. K.; Kim, R. K.; Valbuena, G. N.; Guglietta, S.; Krieg, C.; Damavandi, M. D.; Suwa, T.; Easton, A.; Domingo, E.; Moon, E. J.; Jiang, D.; Jiang, Y.; Koong, A. C.; Woodruff, T. M.; Graves, E. E.; Maughan, T.; Buczacki, S. J.; Stucki, M.; Le, Q.-T.; Leedham, S. J.; Giaccia, A. J.; Olcina, M. M.
Show abstract
An immunosuppressive microenvironment causes poor tumour T-cell infiltration and is associated with reduced patient overall survival in colorectal cancer. How to improve treatment responses in these tumours is still a challenge. Using an integrated screening approach to identify cancer-specific vulnerabilities, we identify complement receptor C5aR1 as a druggable target which when inhibited improves radiotherapy even in tumours displaying immunosuppressive features and poor CD8+ T-cell infiltration. While C5aR1 is well-known for its role in the immune compartment, we find that C5aR1 is also robustly expressed on malignant epithelial cells, highlighting potential tumour-cell specific functions. C5aR1 targeting results in increased NF-{kappa}B-dependent apoptosis specifically in tumours and not normal tissues; indicating that in malignant cells, C5aR1 primarily regulates cell fate. Collectively, these data reveal that increased complement gene expression is part of the stress response mounted by irradiated tumours and that targeting C5aR1 can improve radiotherapy even in tumours displaying immunosuppressive features.
Matching journals
The top 10 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Chronic circadian disruption modulates breast cancer cell stemness and their immune microenvironment to drive metastasis in mice 95%
- Priming versus propagating: distinct immune effects of an alpha- versus beta-particle emitting radiopharmaceutical when combined with immune checkpoint inhibition 95%
- p53 promotes revival stem cells in the regenerating intestine after severe radiation injury 94%
Similar papers in this journal
- Timing anti-PD-L1 checkpoint blockade immunotherapy to enhance tumor irradiation 96%
- GABA(A) receptor activation drives GABARAP-Nix mediated autophagy to radiation-sensitize primary and brain-metastatic lung adenocarcinoma tumors 95%
- Early neutrophilia marked by aerobic glycolysis sustains host metabolism and delays cancer cachexia 93%
Similar papers in this journal
- Immune stromal components impede biological effectiveness of carbon ion therapy in a preclinical model of pancreatic ductal adenocarcinoma 95%
- Sensitization to Ionizing Radiation by MEK inhibition is Dependent on SNAI2 in Fusion-negative Rhabdomyosarcoma 95%
- PLK4 inhibition as a strategy to enhance non-small cell lung cancer radiosensitivity 95%
Similar papers in this journal
- BUB1 regulates non-homologous end joining pathway to mediate radioresistance in triple-negative breast cancer 95%
- Unveiling the role of osteosarcoma-derived secretome in premetastatic lung remodeling 93%
- Asparagine endopeptidase promotes radioresistance in breast cancer through ATR pathway modulation 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.